Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Comment by lscfaon Apr 15, 2023 4:21pm
112 Views
Post# 35396860

RE:Quipt:Business Economics Attractive On Lower Capital Density

RE:Quipt:Business Economics Attractive On Lower Capital Density

10% annual organic growth = 20% annual growth in share value due to leverage of debt financing.



assumptions:

10% organic growth in ebitda   

20%/yr repayments of $73 million credit facility

no expansion to ev/ebitda multiple


 

 

 

Now

1 yr later

2 yrs later

Shs o/s

36,563

36,563

36,563

Sh price US

$6.93

$8.27

$9.70

Mkt cap

253,382

302,352

354,760

Net debt

90,327

75,727

61,127

Ent. Value

343,709

378,079

415,887

Ebitda

49,000

53,900

59,290

EV/ebitda

7.01

7.01

7.01

 

<< Previous
Bullboard Posts
Next >>